1 |
Scarpace PJ, Matheny M, Moore RL, Tumer N. Impaired leptin responsiveness in aged rats. Diabetes 49: 431-435, 2000
DOI
ScienceOn
|
2 |
Shek, EW, Scarpace PJ. Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regul Pept 92(1-3): 65-71, 2000
DOI
|
3 |
Wiernsperger NF, Bailey CJ. The antihyperglycemic effect of metformin: therapeutic and cellular mechanisms. Drugs 58: 31-39, 1999
|
4 |
Fruehwald-Schultes B, Oltmanns KM, Toschek B, Sopke S, Kern W, Born KJ, Fehm HL, Peters A. Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men. Metabolism 51: 531-536, 2002
DOI
ScienceOn
|
5 |
Hawley SA, Gadalla AE, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420-2425, 2002
DOI
ScienceOn
|
6 |
Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50: 1457-1461, 2001
DOI
ScienceOn
|
7 |
Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA. Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130: 2535-2544, 1992
DOI
ScienceOn
|
8 |
Levin BE, Dunn-Meynell AA. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283: R941-R948, 2002
DOI
|
9 |
Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: 569- 574, 2004
DOI
ScienceOn
|
10 |
Morin-Papunen LC, Koivunen RM, Tomas C, Ruokonen A, Martikainen HK. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 83: 2566-2568, 1998
DOI
ScienceOn
|
11 |
Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphine-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338: 1876-1880, 1998
DOI
ScienceOn
|
12 |
Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch Gerontol Geriatr 42: 35-45, 2006
DOI
ScienceOn
|
13 |
Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin- induced resumption of normal mense in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 48: 511-519, 1999
DOI
ScienceOn
|
14 |
Halaas JL, Booze C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci 94: 8878-8883, 1997
|
15 |
Kim YW, Choi DW, Park YH, Huh JY, Won KC, Choi KH, Park SY, Kim JY, Lee SK. Leptin-like effects of MTII are augmented in MSG-obese rats. Regul Pept 127: 63-70, 2005
DOI
|
16 |
Kim YW, Kim JY, Park YH, Park SY, Won KC, Choi KH, Huh JY, Moon KH. Metformin restores leptin sensitivity in high fat obese rats with leptin resistance. Diabetes 53(Suppl 2): A409, 2004
|
17 |
Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 73: 1149-1154, 2000
DOI
ScienceOn
|
18 |
van den Brandt J, Kovacs P, Kloting I. Metabolic syndrome and aging in Wistar Ottawa Karlsburg W rats. Int J Obes Relat Metab Disord 26: 573-576, 2002
DOI
|
19 |
Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43: 647-654, 1994
DOI
ScienceOn
|
20 |
Moghetti P, Castello R, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M. Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85: 139-146, 2000
DOI
ScienceOn
|
21 |
Hundal HG, Ramlal T, Reyes R, Leiter LA. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131: 1165-1173, 1992
DOI
ScienceOn
|
22 |
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002
DOI
ScienceOn
|
23 |
Radziuk J, Bailey CJ, Wiernsperger NF, Yudkin JS. Metformin and its liver targets in the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metab Disord 3: 151-169, 2003
DOI
ScienceOn
|
24 |
Zhou G, Myers R, li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001
DOI
|
25 |
Fernandez-Galaz C, Fernandez-Agullo T, Perez C, Peralta S, Arribas C, Andres A, Carrascosa JM, Ros M. Long-term food restriction prevents ageing-associated central leptin resistance in Wistar rats. Diabetologia 45: 997-1003, 2002
DOI
ScienceOn
|
26 |
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normalweight and obese humans. N Engl J Med 334: 292-295, 1996
DOI
ScienceOn
|
27 |
Glueck CJ, Fontaine RN, Wang P, Subbiah MTR, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy T, Kang JE, McCullough P. Metformin reduces weight, centropedal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 50: 856-861, 2001
DOI
ScienceOn
|
28 |
Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002
DOI
ScienceOn
|